δ-Globin Gene Structure and Expression in the K562 Cell Line

Hemoglobin

Volumn 27, Issue 4, 2003, Pages 219-228

  Poddie, Daniela ^a   Marongiu, Maria F ^a   Ferrari, Silvia Cigliuti ^a   Porcu, Susanna ^a   Ristaldi, Maria S ^a  

^a CNR   (Italy)

Author keywords

Globin gene; Gene expression and structure; K562 cell line

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; DELTA GLOBIN; HEMIN; HEMOGLOBIN ALPHA CHAIN; HEMOGLOBIN DELTA CHAIN; HEMOGLOBIN F; MESSENGER RNA; NUCLEASE S1;

ALPHA CHAIN; ARTICLE; CHRONIC MYELOID LEUKEMIA; COMPARATIVE GENE MAPPING; CONTROLLED STUDY; DRUG POTENCY; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GLOBIN GENE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

GENE EXPRESSION REGULATION; GLOBINS; HEMOGLOBIN A2; HUMANS; K562 CELLS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATION (GENETICS); VARIATION (GENETICS);

EID: 0345327624     PISSN: 03630269     EISSN: None     Source Type: Journal    
DOI: 10.1081/HEM-120026046     Document Type: Article

References (25)

1. 2: origin, evolution, and aftermath. Blood 1991; 78(9):2165-2177.
2. Donze D, Jeancake PH, Townes TM. Activation of δ-globin gene expression by erytroid Krupplelike factor: a potential approach for gene therapy of sickle cell disease. Blood 1996; 88(10):4051-4057.
3. Tang DC, Ebb D, Hardisson RC, Rodgers GP. Restoration of the CAAT box or insertion of the CACCC motif activates δ-globin gene expression. Blood 1997; 90(1):421-427.
4. Ristaldi MS, Casula S, Porcu S, Marongiu MF, Pirastu M, Cao A. Activation of the δ-globin gene by the β-globin gene CACCC motif. Blood Cells Mol Dis 1999; 25(3&3):193-209.
5. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes. 3rd ed. Oxford: Blackwell Scientific Publications, 1981.
6. Lozzio CB, Lozzio RB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45(5):321-328.
7. Dean A, Ley TJ, Humphries RK, Fordis M, Schechter AN. Inducible transcription of five globin genes in K562 human leukemia cells. Proc Natl Acad Sci USA 1983; 80(18):5515-5519.
8. Tuan D, Solomon W, Li Q, London IM. The "β-like-globin" gene domain in human erythroid cells. Proc Natl Acad Sci USA 1985; 82(19):6384-6388.
9. Fordis CM, Anagnou NP, Dean A, Nienhuis AW, Schechter AN. A β-globin gene, inactive in the K562 leukemic cell, functions normally in a heterologous expression system. Proc Natl Acad Sci USA 1984; 81(14):4485-4489.
10. Persons DA, Allay ER, Sabatino DE, Kelly P, Bodine DM, Nienhuis AW. Functional requirements for phenotypic correction of murine β-thalassemia: implications for human gene therapy. Blood 2001; 97(10):3275-3282.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
12. 2 level. Br J Haematol 1990; 74(1):480-486.
13. Berry M, Dillon N, Grosveld F. A single point mutation is the cause of the Greek form of hereditary persistence of fetal hemoglobin. Nature 1992; 358(6386):499-502.
14. Strouboulis J, Dillon N, Grosveld F. Developmental regulation of a complete 70 kb human β-globin locus in transgenic mice. Genes Dev 1992; 6(10):1857-1864.
15. Mookerjee B, Arcasoy MO, Atweh GF. Spontaneous δ- to β-globin switching in K562 human leukemia cells. Blood 1992; 79(3):820-825.
16. Ristaldi MS, Drabek D, Gribnau J, Poddie D, Yannoutsous N, Cao A, Grosveld F, Imam AM. The role of the -50 region of the human γ-globin gene in switching. EMBO J 2001; 20(18):5242-5249.
17. Papadakis M, Papapanagiotou E, Loutradi-Anagnostou A. Scanning method to identify the molecular heterogeneity of δ-globin gene especially in δ-thalassemias: detection of three novel substitutions in the promoter region of the gene. Hum Mutat 1997; 9(5):465-472.
18. Papapanagiotou E, Kollia P, Loutradi A, Loukopoulos D, Papadakis M. Functional analysis of the -65 (A-G) nucleotide substitution in the promoter region of the δ-globin gene. Blood 1998; 92(10):531a.
19. Armstrong JA, Bieker JJ, Emerson BM. A SWI/SNF-related chromatin remodeling complex, E-RC1, required for tissue-specific transcriptional regulation by EKI vitro. Cell 1998; 95(1):93-104.
20. 2 in patients with different β-thalassemia mutations and a δ chain variant. Blood 1990; 76(6):1246-1249.
21. 2: relationship to mutations in the β-gene promoter. Am J Med Sci 1992; 304(2):73-78.
22. Fraser P, Grosveld F. Locus control regions, chromatin activation and transcription. Curr Opin Cell Biol 1998; 10(3):361-365.
23. May C, Rivella S, Callegari J, Heller G, Gaenster KML, Luzzatto L, Sadelain M. Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin. Nature 2000; 406(6791):82-86.
24. Pawliuk R, Westerman KA, Fabry ME, Payen E, Tighe R, Bouhassira EE, Acharya SA, Ellis J, London IM, Eaves CJ, Humphries RK, Beuzard Y, Nagel RL, Leboulch P. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 2001; 294(5550):2368-2371.
25. May C, Rivella S, Chadbum A, Sadelain M. Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene. Blood 2002; 99(6):1902-1908.